• Fri. Oct 13th, 2023

NCB arrests two for buying drugs from abroad using dark web and distributing it in Mumbai

Avatar photo

ByDavid Brown

Jun 23, 2023
NCB arrests two for dark web drug trafficking | Deeplab.com
David Brown

Narcotics Control Bureau (NCB) agents dismantled a DarkNet network, leading to the arrest of two regional sellers in Mumbai.

The two accused are thought to be well educated and recognized authorities in computing connected to the DarkNet.

Additionally, their possession contained 60 grams (125 tablets) of MDMA, also known as Ecstasy. According to the leading drug enforcement organization, the drugs shipment came from the Netherlands and were bought on the DarkNet.

The NCB first learned of a network operating out of Mumbai that was trafficking costly pharmaceuticals bought through online marketplaces.

Two suspects came under the NCB’s scrutiny when the intelligence was further refined. They allegedly sold MDMA throughout Mumbai and the surrounding areas.

NCB officials also learned that they intended to purchase drug shipments.

Based on the agency source, additional attention was placed on the examination of suspicious patterns, transactions, and packages headed for Mumbai because MDMA and other high-value substances are typically purchased from overseas locations, primarily the Netherlands and other European countries.

A package with 125 MDMA pills was seized on April 19th in Mumbai.

According to preliminary analysis, the two accused were the primary recipients of the confiscated package.

After a brief questioning, the two were detained when additional steps were taken, and according to the NCB officer, they confessed to being involved in drug trafficking.

Incriminating evidence was gathered throughout the inquiry and related to purchases, purchases of drugs, and payment activities.
Relying on the Narcotics Drugs and Psychotropic Substances Act, the two suspects have been taken into custody.

Avatar photo

David Brown

With years of expertise in the field, i am bring a wealth of knowledge and insights to our platform. Our editor’s extensive research and understanding of the drug landscape ensure that their content is accurate, informative, and engaging.